• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估健康经济评价系统综述中的可转移性——方法学指导综述。

Assessing transferability in systematic reviews of health economic evaluations - a review of methodological guidance.

机构信息

Institute for Research in Operative Medicine, Faculty of Health-School of Medicine, Witten/Herdecke University, Cologne, Germany.

Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Institute for Health Services and Health System Research, Neuruppin, Germany.

出版信息

BMC Med Res Methodol. 2022 Feb 20;22(1):52. doi: 10.1186/s12874-022-01536-6.

DOI:10.1186/s12874-022-01536-6
PMID:35184733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8858549/
Abstract

OBJECTIVE

For assessing cost-effectiveness, Health Technology Assessment (HTA) organisations may use primary economic evaluations (P-HEs) or Systematic Reviews of Health Economic evaluations (SR-HEs). A prerequisite for meaningful results of SR-HEs is that the results from existing P-HEs are transferable to the decision context (e.g, HTA jurisdiction). A particularly pertinent issue is the high variability of costs and resource needs across jurisdictions. Our objective was to review the methods documents of HTA organisations and compare their recommendations on considering transferability in SR-HE.

METHODS

We systematically hand searched the webpages of 158 HTA organisations for relevant methods documents from 8th January to 31st March 2019. Two independent reviewers performed searches and selected documents according to pre-defined criteria. One reviewer extracted data in standardised and piloted tables and a second reviewer checked them for accuracy. We synthesised data using tabulations and in a narrative way.

RESULTS

We identified 155 potentially relevant documents from 63 HTA organisations. Of these, 7 were included in the synthesis. The included organisations have different aims when preparing a SR-HE (e.g. to determine the need for conducting their own P-HE). The recommendations vary regarding the underlying terminology (e.g. transferability/generalisability), the assessment approaches (e.g. structure), the assessment criteria and the integration in the review process.

CONCLUSION

Only few HTA organisations address the assessment of transferability in their methodological recommendations for SR-HEs. Transferability considerations are related to different purposes. The assessment concepts and criteria are heterogeneous. Developing standards to consider transferability in SR-HEs is desirable.

摘要

目的

为了评估成本效益,卫生技术评估(HTA)机构可能会使用初级经济评估(P-HE)或健康经济评估的系统综述(SR-HE)。SR-HE 结果具有意义的前提是,现有 P-HE 的结果可转移到决策背景(例如,HTA 管辖范围)。一个特别相关的问题是,成本和资源需求在管辖范围内存在高度的可变性。我们的目的是审查 HTA 机构的方法文件,并比较他们对 SR-HE 中可转移性考虑的建议。

方法

我们从 2019 年 1 月 8 日至 3 月 31 日,系统地在 158 个 HTA 机构的网页上手动搜索了相关的方法文件。两名独立的审查员根据预先确定的标准进行搜索和选择文件。一名审查员以标准化和试点表格提取数据,另一名审查员检查数据的准确性。我们使用列表和叙述方式综合数据。

结果

我们从 63 个 HTA 机构中确定了 155 份可能相关的文件。其中,7 份被纳入综合分析。所包括的组织在准备 SR-HE 时具有不同的目的(例如,确定是否需要进行自己的 P-HE)。建议在基本术语(例如可转移性/可推广性)、评估方法(例如结构)、评估标准以及纳入审查过程等方面存在差异。

结论

只有少数 HTA 机构在其关于 SR-HE 的方法建议中涉及可转移性的评估。可转移性考虑与不同的目的有关。评估概念和标准是多种多样的。制定考虑 SR-HE 中可转移性的标准是可取的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e0/8858549/1d22362ac411/12874_2022_1536_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e0/8858549/1d22362ac411/12874_2022_1536_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e0/8858549/1d22362ac411/12874_2022_1536_Fig1_HTML.jpg

相似文献

1
Assessing transferability in systematic reviews of health economic evaluations - a review of methodological guidance.评估健康经济评价系统综述中的可转移性——方法学指导综述。
BMC Med Res Methodol. 2022 Feb 20;22(1):52. doi: 10.1186/s12874-022-01536-6.
2
Assessing context suitability (generalizability, external validity, applicability or transferability) of findings in evidence syntheses in healthcare-An integrative review of methodological guidance.评估医疗保健中证据综合研究结果的上下文适宜性(推广性、外部有效性、适用性或可转移性):方法学指导的综合综述。
Res Synth Methods. 2020 Nov;11(6):760-779. doi: 10.1002/jrsm.1453. Epub 2020 Sep 29.
3
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS.卫生技术评估中经济评估的系统评价:特征和应用方法综述。
Int J Technol Assess Health Care. 2018 Jan;34(6):537-546. doi: 10.1017/S0266462318000624. Epub 2018 Oct 22.
4
Systematic reviews of health economic evaluations: A structured analysis of characteristics and methods applied.系统评价健康经济评估:应用特征和方法的结构化分析。
Res Synth Methods. 2019 Jun;10(2):195-206. doi: 10.1002/jrsm.1342. Epub 2019 Mar 4.
5
Methods for systematic reviews of health economic evaluations: a systematic review, comparison, and synthesis of method literature.卫生经济评估系统评价方法:方法文献的系统评价、比较与综合
Med Decis Making. 2014 Oct;34(7):826-40. doi: 10.1177/0272989X14526470. Epub 2014 Apr 8.
6
Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices.考虑健康技术评估的可转移性:工具、方法和实践的范围综述。
Int J Technol Assess Health Care. 2022 Nov 2;38(1):e78. doi: 10.1017/S026646232200321X.
7
Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.国际卫生技术评估机构经济评价方法——比较分析。
BMC Health Serv Res. 2013 Sep 30;13:371. doi: 10.1186/1472-6963-13-371.
8
Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).患者报告结局(PRO)在卫生技术评估(HTA)中的信息价值。
GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.
9
Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied.系统评价卫生经济评估:系统综述特征和方法应用的研究方案。
Syst Rev. 2017 Dec 2;6(1):238. doi: 10.1186/s13643-017-0639-8.
10
Development, testing and use of data extraction forms in systematic reviews: a review of methodological guidance.系统评价中数据提取表格的开发、测试和使用:方法学指导的综述。
BMC Med Res Methodol. 2020 Oct 19;20(1):259. doi: 10.1186/s12874-020-01143-3.

引用本文的文献

1
How Professional and Market Logics and the Conflict between Institutional Demands Affect Hospital Accreditation Compliance: A Multiple-Case Study in Brazil.专业逻辑与市场逻辑以及机构要求之间的冲突如何影响医院认证合规性:巴西的多案例研究
Healthcare (Basel). 2024 Apr 27;12(9):914. doi: 10.3390/healthcare12090914.
2
Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now?优先研究事项以增强健康偏好研究的信心和接受度:现在应优先考虑哪些问题?
Patient. 2024 Mar;17(2):179-190. doi: 10.1007/s40271-023-00650-x. Epub 2023 Dec 16.
3
A Scoping Review of Economic Evaluations to Inform the Reorientation of Preventive Health Services in Australia.

本文引用的文献

1
Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report.对包含成本和成本效益结果的系统评价的批判性评估:一份药物经济学与结果研究协会良好实践工作组报告
Value Health. 2021 Apr;24(4):463-472. doi: 10.1016/j.jval.2021.01.002.
2
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
3
Assessing context suitability (generalizability, external validity, applicability or transferability) of findings in evidence syntheses in healthcare-An integrative review of methodological guidance.
澳大利亚预防保健服务重新定位的经济评价范围综述
Int J Environ Res Public Health. 2023 Jun 15;20(12):6139. doi: 10.3390/ijerph20126139.
4
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naive unfit CLL without TP53 aberrations.初治不适合化疗的伴或不伴 TP53 异常的 CLL 患者中,靶向治疗与化疗免疫治疗的成本效果比较。
Blood Adv. 2023 Aug 8;7(15):4186-4196. doi: 10.1182/bloodadvances.2023010108.
5
Cost-Effectiveness of Thrombopoietin Mimetics in Patients with Thrombocytopenia: A Systematic Review.促血小板生成素类似物治疗血小板减少症的成本效果评价:系统综述。
Pharmacoeconomics. 2023 Aug;41(8):869-911. doi: 10.1007/s40273-023-01271-w. Epub 2023 May 5.
6
Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward.非手术生物医学 HIV 预防的健康经济学研究:识别差距并提出前进方向。
Pharmacoeconomics. 2023 Jul;41(7):787-802. doi: 10.1007/s40273-022-01231-w. Epub 2023 Mar 11.
7
The cost-effectiveness of different types of educational interventions in type II diabetes mellitus: A systematic review.不同类型教育干预措施在2型糖尿病中的成本效益:一项系统评价
Front Pharmacol. 2022 Jul 22;13:953341. doi: 10.3389/fphar.2022.953341. eCollection 2022.
评估医疗保健中证据综合研究结果的上下文适宜性(推广性、外部有效性、适用性或可转移性):方法学指导的综合综述。
Res Synth Methods. 2020 Nov;11(6):760-779. doi: 10.1002/jrsm.1453. Epub 2020 Sep 29.
4
Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study.经济评估系统评价面临的挑战:近期评价综述及肥胖症案例研究
Pharmacoeconomics. 2020 Mar;38(3):259-267. doi: 10.1007/s40273-019-00878-2.
5
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.《可信系统评价的更新指南:干预措施系统评价的新版Cochrane手册》
Cochrane Database Syst Rev. 2019 Oct 3;10(10):ED000142. doi: 10.1002/14651858.ED000142.
6
Systematic mapping of checklists for assessing transferability.系统绘制清单以评估可转移性。
Syst Rev. 2019 Jan 14;8(1):22. doi: 10.1186/s13643-018-0893-4.
7
SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS.卫生技术评估中经济评估的系统评价:特征和应用方法综述。
Int J Technol Assess Health Care. 2018 Jan;34(6):537-546. doi: 10.1017/S0266462318000624. Epub 2018 Oct 22.
8
How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3).如何准备一份用于为循证医疗决策提供信息的经济评估系统评价:数据提取、偏倚风险及可转移性(第3部分/共3部分)
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):723-732. doi: 10.1080/14737167.2016.1246961. Epub 2016 Oct 21.
9
Methods for systematic reviews of health economic evaluations: a systematic review, comparison, and synthesis of method literature.卫生经济评估系统评价方法:方法文献的系统评价、比较与综合
Med Decis Making. 2014 Oct;34(7):826-40. doi: 10.1177/0272989X14526470. Epub 2014 Apr 8.
10
Assessing the applicability of findings in systematic reviews of complex interventions can enhance the utility of reviews for decision making.评估系统评价中复杂干预措施研究结果的适用性可以提高评价在决策中的实用性。
J Clin Epidemiol. 2013 Nov;66(11):1251-61. doi: 10.1016/j.jclinepi.2013.06.017. Epub 2013 Aug 14.